Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.
Public ClinicalTrials.gov record NCT00293657. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Single-Dose Study, Placebo-Controlled Evaluation of the Safety and Efficacy of Intravenous Lornoxicam in the Acute Treatment of the Headache of Migraine.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for the acute treatment of moderate or severe headache associated with a single migraine attack in patients with a history of migraine. Two-thirds of patients in this study will receive a single dose of intravenous lornoxicam (8mg or 16 mg) and one-third of patients will receive a single dose of an intravenous placebo.
Study identification
- NCT ID
- NCT00293657
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2005
- Primary completion
- Mar 31, 2006
- Completion
- Mar 31, 2006
- Last update posted
- Dec 2, 2012
2005 – 2006
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Clinical Therapeutics | Birmingham | Alabama | 35235 | — |
| University of South Alabama Neurology | Mobile | Alabama | 36693 | — |
| Little Rock Family Practice Clinic | Little Rock | Arkansas | 72205 | — |
| C. Phillip O'Carroll, MD, Inc. | Newport Beach | California | 92660 | — |
| California Medical Clinic for Headache | Santa Monica | California | 90404 | — |
| New England Center for Headache | Stamford | Connecticut | 06902 | — |
| Meridien Research | St. Petersburg | Florida | 33709 | — |
| Premiere Research Institute | West Palm Beach | Florida | 33407 | — |
| Diamond Headache Clinic | Chicago | Illinois | 60614 | — |
| NE Medical Research Associates, Inc. | North Dartmouth | Massachusetts | 02747 | — |
| Michigan Head Pain and Neurological Institute | Ann Arbor | Michigan | 48104 | — |
| Clinical Research Institute | Plymouth | Minnesota | 55441 | — |
| Headache Care Center | Springfield | Missouri | 65807 | — |
| Mercy Health Reserach / Ryan Headache Center | St Louis | Missouri | 63141 | — |
| University Headache Center | Chapel Hill | North Carolina | 27599 | — |
| Headache Wellness Center | Greensboro | North Carolina | 27401 | — |
| North Carolina Clinical Research | Raleigh | North Carolina | 27607 | — |
| Jefferson Headache Center | Philadelphia | Pennsylvania | 19107 | — |
| Clinical Research Associates, Inc. | Nashville | Tennessee | 37203 | — |
| Houston Headache Clinic | Houston | Texas | 77004 | — |
| Jean Brown Research | Salt Lake City | Utah | 84124 | — |
| The Innovative Clinical Research Center | Alexandria | Virginia | 22304 | — |
| Swedish Pain Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00293657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 2, 2012 · Synced Sep 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00293657 live on ClinicalTrials.gov.